The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
about
Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development.Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.Graft-versus-host disease therapy: something else beyond glucocorticoids?
P2860
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The immunological phenotype of ...... host disease: a phase II study
@ast
The immunological phenotype of ...... host disease: a phase II study
@en
type
label
The immunological phenotype of ...... host disease: a phase II study
@ast
The immunological phenotype of ...... host disease: a phase II study
@en
prefLabel
The immunological phenotype of ...... host disease: a phase II study
@ast
The immunological phenotype of ...... host disease: a phase II study
@en
P2093
P2860
P1433
P1476
The immunological phenotype of ...... host disease: a phase II study
@en
P2093
Debbie van Baarle
Eefke Petersen
Ellen Meijer
Floor Pietersma
Frits Gmelig-Meyling
Henk Lokhorst
Henrike Resemann
Jürgen Kuball
Liane te Boome
Marijke van Dijk
P2860
P304
P356
10.3324/HAEMATOL.2011.041814
P577
2011-05-05T00:00:00Z